Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to characterize sepsis?

Sepsis and non-sepsis patients showed distinct gut microbiota profiles in early AT. In sepsis, the loss of taxa involved in key metabolic functions, as short-chain fatty acid production, reflects dysbiosis and may contribute to worse outcomes. Prolonged antibiotic use may favor enteropathogen overgrowth and gut translocation. These findings highlight the potential of microbiota-based strategies to guide antimicrobial therapy and improve clinical outcomes in critically ill patients.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2025-08-22
DOI
https://doi.org/10.3389/fcimb.2025.1622866
Citations
1
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.81

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to characterize sepsis?

Miriane Melo Silveira Moretti, Diego R. Falci, Rafaela Ramalho Guerra, Patricia Orlandi Barth et al.
1 citations
Frontiers in Cellular and Infection Microbiology
Gut microbiota and health
0.81
article

Microbial diversity and composition in the gut microbiome of patients during systemic inflammatory response syndrome: can we use gut bacteria as potential biomarkers to characterize sepsis?

Miriane Melo Silveira Moretti, Diego R. Falci, Rafaela Ramalho Guerra, Patricia Orlandi Barth, Luciana Giordani, Márcio Manozzo Boniatti, Laila Almeida Viana, Gyselle Ribeiro de Carvalho Oliveira, Patrícia da Silva Fernandes, Dariane Castro Pereira, Afonso Luís Barth, Otávio von Ameln Lovison, Giovanna de Ross Forni, Tarsila Vieceli, Fabiana Caroline Zempulski Volpato, William Latosinski Matos, Andreza Francisco Martins
article en
1 citations

Abstract

Sepsis and non-sepsis patients showed distinct gut microbiota profiles in early AT. In sepsis, the loss of taxa involved in key metabolic functions, as short-chain fatty acid production, reflects dysbiosis and may contribute to worse outcomes. Prolonged antibiotic use may favor enteropathogen overgrowth and gut translocation. These findings highlight the potential of microbiota-based strategies to guide antimicrobial therapy and improve clinical outcomes in critically ill patients.

Frontiers in Cellular and Infection MicrobiologyVol. 15
Universidade Federal do Rio Grande do Sul (BR), Hospital de Clínicas de Porto Alegre (BR), Universidade Federal do Paraná (BR)
Instituto Nacional de Pesquisas em Resistência a Antimicrobianos, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Hospital de Clínicas de Porto Alegre, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Fundação Instituto de Pesquisas Econômicas
Openalex Percentile: Top 24%
Gut microbiota and health
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.